Clinical trial Recruiting at 1 site Interventional Ages 4 to 17

French version of the MEPI/MEPS elbow score for kids: validation in a pediatric setting

Official title: Validation, in a Pediatric Population, of a French Translation of the MEPS/MEPI Score

Run by Centre Hospitalier Universitaire, Amiens · NCT07624474 · Data updated 2026-11-12

This study tests whether a French translation of the elbow score MEPI/MEPS can reliably measure elbow pain and function in children aged 4 to 17.

Quick facts

Study typeInterventional
Ages4 Years to 17 Years
SexAll
Enrollment170 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens)
StatusRecruiting
StartedApril 13, 2026
Main results expectedApril 2028
Study endsJuly 2028
Registry record updatedJune 12, 2026
Trial IDNCT07624474 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 4 to 17 years treated or followed for elbow conditions at CHU Amiens, with parental/guardian consent and, when appropriate, child assent.

Probably not a fit

Children without elbow concerns or those unable to comprehend French may have limited benefit from this translation validation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to validate a French translation of the Modified Elbow Performance Index and Modified Elbow Performance Score in a pediatric population. It includes both a pre-test volunteer group without elbow injury and a test volunteer group with an elbow injury, aged 4 to 17, to assess comprehension and scoring consistency. The study will monitor follow-up adherence and parental consent, ensuring language and cognitive suitability for pediatric use. Data collected will focus on how well the translated scale reflects elbow pain and function in daily activities and after injuries or procedures. This work builds on extensive French-language literature where the MEPS/MEPI is used but has not yet undergone pediatric validation with quality criteria.

Why it matters

Potential benefit: If successful, clinicians will have a validated French tool to assess elbow pain and function in children, improving care decisions and tracking over time.

How similar studies have gone: Previous studies have used MEPS/MEPI in pediatric French-language contexts but lacked formal validation in a pediatric population; this study addresses that gap.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pre-test volunteer group:
* Patients aged 4 to 17 years followed in the department without an elbow injury
* Follow-up schedule compatible with the study protocol
* No objection from a parent or legal guardian, with the child's consent if age permits
* Test volunteer group:
* Patients aged 4 to 17 years followed in the department with a diagnosis of an elbow injury
* Follow-up schedule compatible with the study protocol
* No objection from a parent or legal guardian, with the child's consent

Exclusion Criteria:

* Pre-test volunteer group:
* Language barrier, lack of understanding of French
* Refusal to participate
* Confounding factor impairing function
* Opposition of parent or legal guardian and/or refusal of child if age permits
* Test volunteer group:
* Language barrier, lack of understanding of French
* Refusal to participate
* Confounding factor impairing function
* Opposition of parent or legal guardian and/or refusal of child if age permits

Where it's running

  • CHU Amiens
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.